Tarbox Family Office, Inc. Praxis Precision Medicines, Inc. Transaction History

Tarbox Family Office, Inc.

  • $609 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 25, 2022
SELL
$10.21 - $20.29 $612 - $1,217
-60 Closed
0 $0
Q4 2021

Jan 06, 2022
BUY
$16.76 - $22.99 $1,005 - $1,379
60 New
60 $1,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0
View Full List

About Praxis Precision Medicines, Inc.

PRAX Quotes by TradingView
  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $3.52B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Tarbox Family Office, Inc. Portfolio

Follow Tarbox Family Office, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tarbox Family Office, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email